AECOPD病人CO<sub>2</sub>潴留与凝血指标变化的相关性分析

乔云兰; 乔云兰

doi:10.13898/j.cnki.issn.1000-2200.2019.03.016

[1]

中华医学会呼吸病学分会慢性阻塞性肺疾病学组.慢性阻塞性肺疾病诊治指南(2013年修订版)[J].中华结核和呼吸杂志, 2013, 36(4):255. doi: 10.3760/cma.j.issn.1001-0939.2013.04.007

[2]

张杰, 张颖, 余其贵, 等.老年慢性阻塞性肺疾病急性发作患者血清中血管内皮因子变化及其意义[J].安徽医药, 2014, 18(1):109. doi: 10.3969/j.issn.1009-6469.2014.01.034

[3]

RIZKALLAH J, MAN S F, SIN DD.Prevalence of pulmonary embolism in acute exacerbations of COPD:a systematic review and metaanalysis[J].Chest, 2009, 135(3):786. doi: 10.1378/chest.08-1516

[4]

关伟.慢性阻塞性肺疾病合并肺血栓栓塞症的研究进展[J].心肺血管病杂志, 2012, 31(3):342. doi: 10.3969/j.issn.1007-5062.2012.03.032

[5]

段林立, 张挪富, 刘春丽.慢性阻塞性肺疾病急性加重合并静脉血栓症研究进展[J].中华结核和呼吸杂志, 2016, 39(2):130. doi: 10.3760/cma.j.issn.1001-0939.2016.02.013

[6]

VALVI D, MANNINO DM, MVLLEROVA H, et al.Fibrinogen, chronic obstructive pulmonary disease(COPD) and outcomes in two United States cohorts[J].Int J Chron Obstruct Pulmon Dis, 2012, 7:173.

[7]

MANNINO DM, TAL-SINGER R, LOMAS DA, et al.Plasma Fibrinogen as a Biomarker for Mortality and Hospitalized Exacerbations in People with COPD[J].Chronic Obstr Pulm Dis(Miami), 2015, 2(1):23.

[8]

DUVOIX A, DICKENS J, HAQ I, et al.Blood fibrinogen as a biomarker of chronic obstructive pulmonary disease[J].Thorax, 2013, 68(7):670. doi: 10.1136/thoraxjnl-2012-201871

[9]

FRUCHTER O, YIGLA M, KRAMER MR.D-dimer as a prognostic biomarker for mortality in chronic obstructive pulmonary disease exacerbation[J].Am J Med Sci, 2015, 349(1):29. doi: 10.1097/MAJ.0000000000000332